New virus discovered in blood supply: Human hepegivirus-1 (HHpgV-1)  by Cuestas, María Luján
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1ew virus discovered in blood
upply: Human hepegivirus-1
HHpgV-1)
uevo virus descubierto en los bancos de
angre: Hepegivirus humano-1 (HHpgV-1)
ear  Editor,
 wish  to  provide  some  perspective  from  the  viral  com-
unity  with  regard  to  a  recent  article  published  by  the
merican  Society  for  Microbiology  in  the  medical  journal
Bio.  The  research  group  led  by  Amit  Kapoor  discovered
 virus  that  shares  features  with  hepatitis  C  virus  (HCV)  and
uman  pegivirus  (HPgV;  formerly  known  as  GB  virus  C  or
epatitis  G  virus)1;  both  of  them,  members  of  the  family
laviviridae.  The  new  virus,  named  human  hepegivirus-
 (HHpgV-1)  is  a  blood-borne  virus  that  was  found  in
erum  samples  from  two  blood  transfusion  recipients
nd  two  hemophilia  patients  that  received  blood-derived
roducts.
Since  HPgV,  Torque  teno  virus  (or  transfusion-transmitted
irus,  TTV),  TTV-like  minivirus  (TLMV)  and  SEN  virus
SENV)  were  discovered  in  the  years  1995,  1997  and
000  respectively,  no  more  transfusion-associated  virus
as  been  described  so  far.  Furthermore,  many  cases  of
ost-transfusion  hepatitis  of  unknown  etiology  still  occur
mong  blood  recipients.  If  HHpgV-1  is  going  to  be  a  sig-
iﬁcant  cause  of  human  hepatitis,  nobody  knows.  What
t  is  known  is  that  most  HPgV  infections  are  asymp-
omatic,  transient  and  self-limiting2.  In  contrast,  chronic
nfection  by  HCV  is  a  problem  of  health  concern  of
xtraordinary  magnitude,  that  represents  the  most  com-
on  cause  of  many  costly  and  morbid  complications
ncluding  liver  cirrhosis,  end-stage  liver  disease  and  liver
ransplantation3,4.
I would  like  to  shed  some  more  light  on  the  implica-
ions  associated  with  the  new  blood-borne  virus  discovered.
lood  transfusions  have  been  and  continue  to  be  a  valu-
ble  way  to  save  lives  and  improve  health.  Only  in  the
nited  States,  more  than  300  million  blood  components
re  transfused  every  year.  However,  a  myriad  of  agents
2
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e  added  to  the  list  of  virus  that  may  be  studied  at
emotherapy  Services.  Therefore,  epidemiological  research
orks  from  different  parts  of  the  world  are  really  essential
or  gaining  insight  into  the  prevalence  and  characteris-
ics  of  this  novel  blood-borne  virus.  Once  available,  such
nformation  will  be  extremely  valuable  both  for  design-
ng  new  assays  for  its  detection  as  well  as  for  avoiding
alse  negative  results  when  screening  its  presence  in  blood
onors.  Surveillance  of  the  different  agents  that  may  poten-
ially  be  transmitted  by  blood  is  mandatory  to  ensure  the
afety  of  this  valuable  resource  for  medicine  and  public
ealth.
Finally,  as  the  ﬁeld  of  molecular  biology  advances,  the
iscovery  of  new  viruses  raises  the  need  for  a  valid  set  of
riteria  to  verify  that  exists  a  causal  relationship  between
he  presence  of  certain  viruses  and  a  speciﬁc  disease,  or
ven  if  its  presence  is  associated  to  poorer  prognosis  of
iver  disease  in  those  patients  co-infected  with  hepatotropic
iruses  such  as  hepatitis  B  virus  (HBV)  or  HCV  or  between  the
resence  of  this  newly  identiﬁed  virus  and  its  pathogenic
volution  in  human  immunodeﬁciency  virus  (HIV)-infected
atients,  just  to  mentioned  some  examples.  The  investi-
ation  of  the  prevalence  and  impact  of  coinfections  with
HpgV-1  and  known  hepatitis  viruses  or  HIV  would  provide
dditional  information  for  the  assessment  of  the  relationship
etween  this  novel  virus  and  disease.
So  far,  the  two  most  relevant  ﬁndings  with  potential
edical  impact  were  the  persistent  long-term  HHpgV-1
iremia  in  two  hemophilia  patients  and,  the  genetic  simi-
arity  among  HHpgV1  with  both  highly  pathogenic  HCV  and
he  apparently  nonpathogenic  HPgV1.
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